Zur Frage der ChimÄrenbildung und Umstimmbarkeit

Ohne Zusammenfassung     

Spiza?tus alboniger (Blyth) undSpiza?tus nanus Wallace, zwei f?lschlich vereinigte Arten

Ohne Zusammenfassung     

Oekologische Sippen-, Rassen- und Artunterschiede bei V?geln

Ohne ZusammenfassungVortrag, gehalten auf der 61. Jahresversammlung der D. O. G. am 3. Juli 1943.     

Age of menarche in pigtail monkeys (Macaca nemestrina): A cross-sectional survey of perineal tumescence

A four-month survey of perineal tumescence in 131 young female pigtail monkeys ($\text{Macaca nemestrina}$) revealed that most females had begun to swell by the time they were 3 years old. Those that had not begun to swell by that time were generally of lower weight than their peers. Those that tumesced before they were 3 years old tended to be heavier than their peers, but were not necessarily heavier than older, nonswelling females.     

Pretubulysin: a new option for the treatment of metastatic cancer

Tubulin-binding agents such as taxol, vincristine or vinblastine are well-established drugs in clinical treatment of metastatic cancer. However, because of their highly complex chemical structures, the synthesis and hence the supply issues are still quite challenging. Here we set on stage pretubulysin, a chemically accessible precursor of tubulysin that was identified as a potent microtubule-binding agent produced by myxobacteria. Although much simpler in chemical structure, pretubulysin abrogates proliferation and long-term survival as well as anchorage-independent growth, and also induces anoikis and apoptosis in invasive tumor cells equally potent to tubulysin. Moreover, pretubulysin posseses in vivo efficacy shown in a chicken chorioallantoic membrane (CAM) model with T24 bladder tumor cells, in a mouse xenograft model using MDA-MB-231 mammary cancer cells and finally in a model of lung metastasis induced by 4T1 mouse breast cancer cells. Pretubulysin induces cell death via the intrinsic apoptosis pathway by abrogating the expression of pivotal antiapoptotic proteins, namely Mcl-1 and Bcl-x_L, and shows distinct chemosensitizing properties in combination with TRAIL in two- and three-dimensional cell culture models. Unraveling the underlying signaling pathways provides novel information: pretubulysin induces proteasomal degradation of Mcl-1 by activation of mitogen-activated protein kinase (especially JNK (c-Jun N-terminal kinase)) and phosphorylation of Mcl-1, which is then targeted by the SCF^Fbw7 E3 ubiquitin ligase complex for ubiquitination and degradation. In sum, we designate the microtubule-destabilizing compound pretubulysin as a highly promising novel agent for mono treatment and combinatory treatment of invasive cancer.